rs190712778
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The ENST00000369850.10(FLNA):c.5911A>T(p.Ile1971Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000038 in 1,210,436 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 20 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000369850.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNA | NM_001110556.2 | c.5911A>T | p.Ile1971Phe | missense_variant | 37/48 | ENST00000369850.10 | NP_001104026.1 | |
FLNA | NM_001456.4 | c.5887A>T | p.Ile1963Phe | missense_variant | 36/47 | NP_001447.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNA | ENST00000369850.10 | c.5911A>T | p.Ile1971Phe | missense_variant | 37/48 | 1 | NM_001110556.2 | ENSP00000358866 |
Frequencies
GnomAD3 genomes AF: 0.000106 AC: 12AN: 112878Hom.: 0 Cov.: 26 AF XY: 0.000114 AC XY: 4AN XY: 35014
GnomAD3 exomes AF: 0.0000551 AC: 10AN: 181471Hom.: 0 AF XY: 0.0000444 AC XY: 3AN XY: 67611
GnomAD4 exome AF: 0.0000310 AC: 34AN: 1097504Hom.: 0 Cov.: 33 AF XY: 0.0000441 AC XY: 16AN XY: 363178
GnomAD4 genome AF: 0.000106 AC: 12AN: 112932Hom.: 0 Cov.: 26 AF XY: 0.000114 AC XY: 4AN XY: 35078
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 25, 2022 | BP4, PP3 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 22, 2023 | See Variant Classification Assertion Criteria. - |
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2018 | The p.I1963F variant (also known as c.5887A>T), located in coding exon 35 of the FLNA gene, results from an A to T substitution at nucleotide position 5887. The isoleucine at codon 1963 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species; however, phenylalanine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 10, 2023 | - - |
FLNA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 08, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at